跳转至内容
Merck

SML0199

Sigma-Aldrich

Metaxalone

≥98% (HPLC)

别名:

5-(3,5-Dimethylphenoxymethyl)-2-oxazolidinone, 5-[(3,5-Xylyloxy)methyl]-2-oxazolidinone, AHR 438, Metaxalon, Metazalone, Metazolone, NSC 170959

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C12H15NO3
CAS号:
分子量:
221.25
EC號碼:
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

化驗

≥98% (HPLC)

形狀

powder

顏色

white to tan

溶解度

DMSO: ≥2 mg/mL (warmed to 60 °C)

儲存溫度

−20°C

SMILES 字串

Cc1cc(C)cc(OCC2CNC(=O)O2)c1

InChI

1S/C12H15NO3/c1-8-3-9(2)5-10(4-8)15-7-11-6-13-12(14)16-11/h3-5,11H,6-7H2,1-2H3,(H,13,14)

InChI 密鑰

IMWZZHHPURKASS-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

應用

Metaxalone may be used in cell signaling studies.

生化/生理作用

Metaxalone is a muscle relaxant. The mechanism of action of metaxalone in humans is not fully understood. It was suggested that it acts through general central nervous system depression.
Metaxalone is effective to relieve pain due to acute skeletal muscle pain caused due to musculoskeletal conditions and sprains.

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Acute Tox. 4 Oral

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Justin L Poklis et al.
Journal of analytical toxicology, 28(6), 537-541 (2004-11-02)
The case history and toxicological findings of a fatal multi-drug overdose involving metaxalone (Skelaxin) are presented. Gas-liquid chromatography with flame-ionization detection and gas chromatography-mass spectrometry were used to determine the following drug concentrations (mg/L) in aortic blood: 19 mg/L metaxalone;
Rakshit Kanubhai Trivedi et al.
Scientia pharmaceutica, 80(2), 353-366 (2012-08-17)
A simple, sensitive and reproducible reversed phase ultra performance liquid chromatography (RP-UPLC) coupled with a photodiode array detector method was developed for the quantitative determination of metaxalone (META) in pharmaceutical dosage forms. The method is applicable to the quantification of
Peter P Toth et al.
Clinical therapeutics, 26(9), 1355-1367 (2004-11-09)
Low back pain is a leading reason for primary care visits. Many treatment options are available, but some lack scientific support. The aim of this review was to discuss the etiology of low back pain and the relative risks and

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门